AngioDynamics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.5% | -4.9% | -5.6% | -4.9% | +7.9% | -1.2% | +11.3% | -5.5% | +4.9% | -1.3% | +10.4% | – | |
| – | +0.5% | +1.3% | -17.4% | -5.2% | +7.1% | +0.6% | +14.5% | -10.8% | +10.2% | -0.9% | +0.7% | – | |
| – | +0.5% | -10.9% | +7.4% | -4.7% | +8.7% | -2.6% | +8.6% | -0.9% | +0.7% | -1.6% | +19.1% | – | |
| – | +9.0% | -5.4% | -17.9% | -6.5% | +2.4% | +7.4% | -4.7% | -2.6% | +21.1% | -8.8% | +15.4% | – | |
| – | -14.4% | +13.9% | -1.3% | +5.1% | -5.3% | +1.0% | -2.4% | +22.7% | -19.1% | +5.6% | -4.2% | – | |
| – | +961.3% | +341.6% | -77.5% | -5.9% | +2.4% | -4.3% | -1.7% | +9.4% | -15.0% | +7.3% | +45.6% | – | |
| – | -137.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +348.7% | -26.2% | +43.9% | – | – | – | – | – | +2,450.0% | -13.7% | +19.3% | – | |
| – | -136.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -173.1% | – | – | -182.7% | – | – | – | -107.7% | – | +2,983.3% | – | |
| – | -163.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -290.3% | – | -118.3% | – | -318.8% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.